RPG Life Sciences
RPGLIFE.NS
#6996
Rank
โ‚ฌ0.41 B
Marketcap
24,93ย โ‚ฌ
Share price
-2.04%
Change (1 day)
67.56%
Change (1 year)

P/E ratio for RPG Life Sciences (RPGLIFE.NS)

P/E ratio as of December 2024 (TTM): 47.1

According to RPG Life Sciences 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 47.1059. At the end of 2022 the company had a P/E ratio of 21.6.

P/E ratio history for RPG Life Sciences from 2013 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202221.67.54%
202120.118.75%
202016.9-9.22%
201918.6-50.01%
201837.3-42.53%
201764.977.01%
201636.72.59%
201535.7-200.86%
2014-35.4-1928.53%
20131.94

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.